Depression and Anxiety in Pregnancy during COVID-19: A Rapid Review and Meta-Analysis Lianne M. TOMFOHR-MADSEN, PhD1,2,3 Nicole RACINE, PhD1,2 Gerald F GIESBRECHT PhD1,2 Catherine LEBEL, PhD2,4 Sheri MADIGAN, PhD1,2 1. Department of Psychology, University of Calgary, Calgary, AB 2. Alberta Children’s Hospital Research Institute (ACHRI), Calgary, AB 3. Department of Pediatrics, University of Calgary, Calgary, AB 4. Department of Radiology, University of Calgary, Calgary, AB Disclosure Statement: The authors report no conflicts of interest. Financial Support: Salary support for this project was provided by the Canadian Child Health Clinician Scientist Program (CCHCSP; LTM). Address correspondence to: Lianne Tomfohr-Madsen, PhD, Department of Psychology, University of Calgary, 2500 University Drive, NW, Calgary, AB, T2N 1N4,
[email protected] 1 Abstract Objective: The present study rapidly reviewed and meta-analyzed the worldwide prevalence of depression and anxiety among pregnant women during the COVID-19 pandemic. Methods: A systematic search of the literature and meta-analyses were conducted. Results: Fifteen studies with 11,091 participants met inclusion criteria. Depression was assessed in 11 studies, with a pooled prevalence of .265 or 26.5% and anxiety in 12 studies, with a pooled prevalence of .335 or 33.5%. Conclusions: Rates of depression and anxiety during pregnancy are elevated during the pandemic. There is an urgent need to ensure screening and treatment for depression and anxiety during pregnancy. Keywords: Pregnancy, COVID-19, Mental Health, Depression, Anxiety, Meta-Analysis 2 Exposure to natural disasters and disease outbreaks increases the prevalence of mental health problems, including during pregnancy.1 Early reports from pregnant cohorts around the world suggest elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic; however, the exact prevalence is unknown.